![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA OK’s Mobile App for Assisting Opioid Use Disorder Treatments
FDA OK’s Mobile App for Assisting Opioid Use Disorder Treatments
![AppPhone.gif](https://www.fdanews.com/ext/resources/test/Drug-Images3/AppPhone.gif?t=1576815703&width=430)
December 11, 2018
The FDA granted 510(k) clearance for Pear Therapeutics’ reSET-O, an app designed to help patients with opioid use disorder stick with their recovery programs.
The app is meant to be used with buprenorphine and contingency management, a behavior modification therapy.
After receiving a doctor’s prescription for the app, it can be downloaded onto a mobile device for use with active participation in an opioid use disorder treatment program. It serves as a training, monitoring and reminder tool for patients and healthcare providers.
Upcoming Events
-
21Oct